Ignite Planners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$802K Sell
8,867
-1,499
-14% -$126K 0.11% 182
2026
Q1
$830K Hold
10,366
0.13% 170
2025
Q4
$843K Sell
10,366
-75
-0.7% -$6.16K 0.13% 165
2025
Q3
$812K Hold
10,441
0.13% 161
2025
Q2
$799K Sell
10,441
-19,169
-65% -$1.43M 0.14% 155
2025
Q1
$2.23M Buy
+29,610
New +$2.12M 0.44% 55
2024
Q1
Sell
-6,397
Closed -$483K 291
2023
Q4
$483K Hold
6,397
0.14% 159
2023
Q3
$462K Buy
6,397
+2
+0% +$161 0.14% 164
2023
Q2
$577K Sell
6,395
-675
-10% -$58.7K 0.22% 101
2023
Q1
$585K Hold
7,070
0.24% 102
2022
Q4
$552K Buy
7,070
+1,747
+33% +$135K 0.23% 113
2022
Q3
$455K Sell
5,323
-952
-15% -$91.6K 0.36% 84
2022
Q2
$617K Sell
6,275
-9,004
-59% -$932K 0.51% 57
2022
Q1
$1.81M Buy
15,279
+424
+3% +$47.6K 1.21% 13
2021
Q4
$1.72M Buy
+14,855
New +$1.73M 1.12% 15

Other funds holding EW

Ignite Planners's EW Position: Q2 2026 in Review

Ignite Planners reduced its Edwards Lifesciences (EW) stake by 14% in Q2 2026, selling an estimated $126K and leaving 8,867 shares worth $802K. The position accounts for 0.11% of the portfolio, ranked #182.

Ignite Planners first reported a position in EW in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.23M in Q1 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ignite Planners held 8,867 shares of Edwards Lifesciences worth $802K as of Q2 2026.
  • Ignite Planners sold 1,499 Edwards Lifesciences shares in Q2 2026, an estimated $126K.
  • Edwards Lifesciences made up 0.11% of Ignite Planners's portfolio in Q2 2026, its #182 holding.
  • Ignite Planners first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 15 quarters since.
  • Ignite Planners's Edwards Lifesciences position peaked at $2.23M in Q1 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.